Biotechnology
- 1055.061
- +3.349+0.32%
Jefferies Sticks to Their Buy Rating for Telix Pharmaceuticals Ltd. (TLPPF)
Jefferies Sticks to Their Buy Rating for Clarity Pharmaceuticals Ltd. (CU6)
Morgans Financial Downgrades Clinuvel Pharmaceuticals to Hold From Add; Price Target Is AU$16
Euroz Hartleys Upgrades Botanix Pharmaceuticals' to Buy From Speculative Buy, Adjusts Price Target to AU$0.47 From AU$0.33
Canaccord Genuity Starts PYC Therapeutics at Buy With AU$0.22 Price Target
Jarden Research Adjusts Telix Pharmaceuticals' Price Target to AU$16.62 From AU$13.94, Keeps at Buy
Analysts Offer Insights on Healthcare Companies: Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF), CSL (OtherCMXHF) and Telix Pharmaceuticals Ltd. (OtherTLPPF)
Euroz Hartleys Adjusts Dimerix's Price Target to AU$0.86 From AU$0.80, Keeps at Speculative Buy
Jarden Remains a Buy on Telix Pharmaceuticals Ltd. (TLPPF)
Analysts Offer Insights on Healthcare Companies: Immutep Ltd (OtherPRRUF) and Redcare Pharmacy (GB:0RJT)
Telix Pharmaceuticals Ltd. (TLPPF) Gets a Buy From Wilsons
Evans & Partners Starts Botanix Pharmaceuticals at Speculative Buy With AU$0.55 Price Target
UBS Keeps Their Buy Rating on Telix Pharmaceuticals Ltd. (TLPPF)
Euroz Hartleys Adjusts Botanix Pharmaceutical's Price Target to AU$0.33 From AU$0.30, Keeps at Speculative Buy
Bell Potter Downgrades Telix Pharmaceuticals Ltd. (TLPPF) to a Hold
Bell Potter Downgrades Telix Pharmaceuticals to Hold From Buy, Price Target Is AU$14.50
Canaccord Starts Immutep at Buy, Price Target Is AU$1.00
Analysts Offer Insights on Healthcare Companies: Addus Homecare (ADUS), Telix Pharmaceuticals Ltd. (OtherTLPPF) and Intuitive Surgical (ISRG)
Wilsons Sticks to Its Buy Rating for Immutep Ltd (PRRUF)
Jarden Remains a Buy on Telix Pharmaceuticals Ltd. (TLPPF)